How long should patients with migraine continue to receive prophylactic topiramate?: Commentary

Todd J. Schwedt

doi:10.1038/ncpneuro0770

How long should patients with migraine continue to receive prophylactic topiramate? Commentary

Neurology

Research output: Contribution to journal › Short survey › peer-review

Original language	English (US)
Pages (from-to)	294-295
Number of pages	2
Journal	Nature Clinical Practice Neurology
Volume	4
Issue number	6
DOIs	https://doi.org/10.1038/ncpneuro0770
State	Published - Jun 2008

ASJC Scopus subject areas

Clinical Neurology
Cellular and Molecular Neuroscience

Access to Document

10.1038/ncpneuro0770

Cite this

@article{0113a1cd397e4c8498ada5f17e1ab333,

title = "How long should patients with migraine continue to receive prophylactic topiramate?: Commentary",

author = "Schwedt, {Todd J.}",

year = "2008",

month = jun,

doi = "10.1038/ncpneuro0770",

language = "English (US)",

volume = "4",

pages = "294--295",

journal = "Nature Clinical Practice Neurology",

issn = "1745-834X",

publisher = "Nature Publishing Group",

number = "6",

}

TY - JOUR

T1 - How long should patients with migraine continue to receive prophylactic topiramate?

T2 - Commentary

AU - Schwedt, Todd J.

PY - 2008/6

Y1 - 2008/6

UR - http://www.scopus.com/inward/record.url?scp=44949116098&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=44949116098&partnerID=8YFLogxK

U2 - 10.1038/ncpneuro0770

DO - 10.1038/ncpneuro0770

M3 - Short survey

C2 - 18349853

AN - SCOPUS:44949116098

SN - 1745-834X

VL - 4

SP - 294

EP - 295

JO - Nature Clinical Practice Neurology

JF - Nature Clinical Practice Neurology

IS - 6

ER -

How long should patients with migraine continue to receive prophylactic topiramate? Commentary

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this